Condition: AsthmaInterventions: Drug: Seretide Diskus and charcoal; Drug: Seretide Diskus; Drug: SF Easyhaler and charcoal; Drug: SF EasyhalerSponsors: Orion Corporation, Orion Pharma; Orion Corporation, Orion PharmaRecruiting – verified May 2013 View full post on ClinicalTrials.gov: asthma | received in the last 14 days
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Condition: AsthmaInterventions: Drug: dupilumab SAR231893 (REGN668); Drug: placeboSponsors: Sanofi; Sanofi; Regeneron PharmaceuticalsNot yet recruiting – verified March 2013 View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Clinical Pharmacology Study of CHF1535 pMDI 50/6 µg Versus The Free Combination In Asthmatic Children 5-11 Years Old
Condition: AsthmaInterventions: Drug: CHF1535 pMDI + AC Plus; Drug: BDP + AC Plus; Drug: Formoterol + AC PlusSponsors: Chiesi Farmaceutici S.p.A.; Chiesi Farmaceutici S.p.A.Completed – verified May 2013 View full post on ClinicalTrials.gov: asthma | received in the last 14 days
CLINICAL PHARMACOLOGY STUDY OF A FIXED COMBINATION OF BECLOMETHASONE DIPROPIONATE 50µg PLUS FORMOTEROL FUMARATE 6 µg VERSUS THE FREE COMBINATION OF BECLOMETHASONE HFA pMDI AND FORMOTEROL HFA pMDI AVAILABLE ON THE MARKET USING THE AEROCHAMBER PLUS™ SPACER DEVICE IN ASTHMATIC CHILDREN
Condition: AsthmaInterventions: Drug: CHF1535 pMDI + AC Plus; Drug: BDP and Formoterol + AC PlusSponsors: Chiesi Farmaceutici S.p.A.; Chiesi Farmaceutici S.p.A.Completed – verified April 2013 View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Study of Safety of Foradil in Patients With Persistent Asthma
Condition: Persistent AsthmaInterventions: Drug: Formoterol; Drug: Fluticasone propionate 100 mcg; Drug: Fluticasone propionate 250 mcg; Drug: Fluticasone propionate 500 mcg; Drug: PlaceboSponsors: Novartis; Novartis PharmaceuticalsNot yet recruiting – verified April 2013 View full post on ClinicalTrials.gov: asthma | received in the last 14 days
A Study to Determine Long-term Safety of Mepolizumab in Asthmatic Subjects
Condition: AsthmaIntervention: Biological: MepolizumabSponsors: GlaxoSmithKline; GlaxoSmithKlineNot yet recruiting – verified April 2013 View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Effects of Multidisciplinary Interventions in Elderly Asthma Patients With Risk of Acute Exacerbation
Conditions: Asthma; AgedInterventions: Dietary Supplement: Magnesium; Behavioral: Education for asthma action plan; Behavioral: hot-lines for acute exacerbation of asthma; Behavioral: Inhaler technique trainingSponsors: Seoul National University Hospital; Sang-Heon Cho; Korean Center for Disease Control and PreventionActive, not recruiting – verified April 2013 View full post on ClinicalTrials.gov: asthma | received in…
L-arginine in Severe Asthma Patients Grouped by Exhaled Nitric Oxide Levels
Condition: AsthmaInterventions: Drug: L-Arginine; Drug: PlaceboSponsors: University of California, Davis; University of California, Davis; National Heart, Lung, and Blood Institute (NHLBI)Not yet recruiting – verified April 2013 View full post on ClinicalTrials.gov: asthma | received in the last 14 days
A Study to Assess the Bronchodilator Effect of a Single Dose of Fluticasone Furoate (FF)/ Vilanterol (VI) 100/25 Micrograms (Mcg) Combination When Administered in Adult Patients With Asthma
Condition: AsthmaInterventions: Drug: FF/VI 100/25 mcg; Drug: PlaceboSponsors: GlaxoSmithKline; GlaxoSmithKlineNot yet recruiting – verified April 2013 View full post on ClinicalTrials.gov: asthma | received in the last 14 days